Shaha A R, Shah J P, Loree T R
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Am J Surg. 1997 Nov;174(5):474-6. doi: 10.1016/s0002-9610(97)00158-x.
The initial presentation of distant metastases in patients with differentiated thyroid cancer is a rare event. Interestingly, if managed appropriately, the long-term survival in this group of patients is approximately 43%. We intend to review our experience of patients presenting initially with distant metastatic disease in a large series of differentiated thyroid cancer patients.
In the entire series of 1,038 consecutive patients treated at Memorial Sloan-Kettering Cancer Center from 1930 to 1985, 44 patients presented initially with distant metastases (4%). There were 22 male and 22 female patients ranging in age from 7 to 75 years with a mean age of 51 years. Patients were analyzed for their prognostic factors, and the survival curves were drawn by the Kaplan-Meier method. Univariate and multivariate analyses were performed by the Cox regression model.
There were 19 patients presenting with distant metastases in 810 patients presenting with papillary thyroid cancer (2.3%). The incidence was high in patients with follicular thyroid cancer (11%). It is interesting to note that the highest incidence of presentation with distant metastatic disease was in patients above the age of 45 and with follicular thyroid carcinoma. The long-term survival in this group is 43% compared with 86% in patients presenting without distant metastasis (P < 0.001). There was no statistical difference in survival of patients below or above the age of 45.
Even though the presence of distant metastasis at the time of initial presentation in other cancers is considered to be of grave prognosis, for patients with differentiated thyroid cancer, the long-term survival is still 43%. The incidence of distant metastasis is highest in patients with follicular thyroid cancer. Appropriate initial evaluation and treatment will lead to satisfactory long-term survival.
分化型甲状腺癌患者出现远处转移的初始表现是一种罕见情况。有趣的是,如果处理得当,这类患者的长期生存率约为43%。我们打算回顾在一大系列分化型甲状腺癌患者中最初表现为远处转移性疾病患者的治疗经验。
在1930年至1985年于纪念斯隆凯特琳癌症中心接受治疗的连续1038例患者中,44例患者最初表现为远处转移(4%)。有22例男性和22例女性患者,年龄从7岁至75岁不等,平均年龄为51岁。对患者的预后因素进行分析,并采用Kaplan-Meier法绘制生存曲线。通过Cox回归模型进行单因素和多因素分析。
在810例乳头状甲状腺癌患者中有19例出现远处转移(2.3%)。滤泡状甲状腺癌患者的发生率较高(11%)。值得注意的是,出现远处转移性疾病的最高发生率见于45岁以上且患有滤泡状甲状腺癌的患者。该组患者的长期生存率为43%,而无远处转移患者的长期生存率为86%(P<0.001)。45岁以下或以上患者的生存率无统计学差异。
尽管在其他癌症中初始表现时出现远处转移被认为预后严重,但对于分化型甲状腺癌患者,长期生存率仍为43%。远处转移的发生率在滤泡状甲状腺癌患者中最高。适当的初始评估和治疗将带来令人满意的长期生存。